Intensity Therapeutics to Participate in Panel at 2019 BIO CEO & Investor Conference
05 févr. 2019 07h35 HE
|
Intensity Therapeutics Inc
WESTPORT, Conn., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Intensity Therapeutics, Inc., a clinical-stage biotechnology company developing proprietary technology and products to kill tumors and increase...
Intensity Therapeutics Forms Scientific Advisory Board Comprised of World-Leading Oncologists and Scientists
22 oct. 2015 07h35 HE
|
Intensity Therapeutics Inc
Westport, CT, Oct. 22, 2015 (GLOBE NEWSWIRE) -- Intensity Therapeutics, Inc., a privately-held biotechnology company developing proprietary immune cell activating anti-cancer drug products, announced...